Introduction: Numerous biomarkers have been evaluated for the diagnosis, assessment of
disease activity, prognosis, and response to treatment in sarcoidosis. In this report, we …

Background: Renin–angiotensin system inhibitors (RAS inhibitors) are antihypertensive
agents with potential antitumor effects. However, various studies have yielded conflicting …

Recent studies on the pathophysiology of COVID-19 are indicating that the Angiotensin
convertase enzyme 2 (ACE-2) and transmembrane serine protease 2 (TMPRSS2) can act as …

Simple Summary We present eight core attributes of cancer growth that we must address for
a more effective treatment than we currently have. To do this we outline why a regimen …

Background Patients with advanced biliary tract cancers (BTCs) have poor prognoses and
limited therapeutic options. Renin-angiotensin antagonists (ACE-I/ARBs), statins, and …

The erythroblastic leukemia viral oncogene homolog (ErBb) family consists of the receptor
tyrosine kinases (RTK) epidermal growth factor receptor (EGFR; also called ERBB1) …

Background: SARS-CoV-2, the cause of the worldwide COVID-19 pandemic, utilizes the
mechanism of binding to ACE2 (a crucial component of the renin-angiotensin system [RAS]) …

Cancer is the leading cause of death in the USA, and the incidence of cancer increases
dramatically with age. Beta-adrenergic blockers appear to have a beneficial clinical effect in …

Background and aims Clinicopathologic and molecular studies have provided new insights
and understanding on the pathological events during ovarian carcinogenesis. Moreover …

Cholangiocarcinoma (CCA) is a fatal disease that is typically diagnosed late and treated
ineffectively. As the morbidity and mortality rates for CCA rise markedly, patietns with CCA …